Exhibit 5.1
[LETTERHEAD OF WILSON SONSINI GOODRICH & ROSATI, P.C.]
September 11, 2018
Infinera Corporation
140 Caspian Court
Sunnyvale, California 94089
Re: Registration Statement on FormS-3
Ladies and Gentlemen:
We have acted as counsel to Infinera Corporation, a Delaware corporation (the “Company”), in connection with the filing by the Company with the Securities and Exchange Commission (the “Commission”) on September 5, 2018 of a registration statement on Form.S-3 (the “Registration Statement”), under the Securities Act of 1933, as amended (the “Act”), that is automatically effective under the Act pursuant to Rule 462(e) promulgated thereunder. The Registration Statement relates to, among other things, the proposed issuance and sale, from time to time, by the Company of debt securities (the “Debt Securities”), with an indeterminate amount as may at various times be issued at indeterminate prices, in reliance on Rule 456(b) and Rule 457(r) under the Act. The Debt Securities are to be sold from time to time as set forth in the Registration Statement, the prospectus contained therein (the “Prospectus”), and the supplements to the Prospectus.
Pursuant to the Registration Statement, the Company has issued $402,500,000 aggregate principal amount of Convertible Senior Notes due 2024 (the “Notes”), all of which have been sold to Morgan Stanley & Co. LLC (the “Underwriter”), pursuant to that certain Underwriting Agreement, dated as of September 6, 2018, between the Company and the Underwriter (the “Underwriting Agreement”).
The Notes have been issued in the form set forth in the Indenture, dated as of September 11, 2018 (the “Base Indenture”), by and between the Company and U.S. Bank National Association, as trustee (the “Trustee”) and the First Supplemental Indenture dated as of September 11, 2018 (the “First Supplemental Indenture” and together with the Base Indenture, the “Indenture”), by and between the Company and the Trustee. The Notes are also initially convertible into up to 52,995,391 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) (such number of shares of Common Stock issuable upon conversion of the Notes referred to herein as, the “Conversion Shares”).
We have examined the Registration Statement, together with the exhibits thereto and the documents incorporated by reference therein; the base prospectus, dated September 5, 2018, together with the documents incorporated by reference therein, filed with the Registration Statement relating to the offering of the Notes (the “Base Prospectus”); the preliminary prospectus supplement, dated September 5, 2018, in the form filed with the Commission pursuant to Rule 424(b) of the Securities Act relating to the offering of the Notes; the free writing prospectus, dated September 6, 2018, in the form filed with the Commission pursuant to Rule 433 of the Securities Act; the final prospectus supplement, dated September 6, 2018 in the form filed with the Commission pursuant to Rule 424(b) of the Securities Act relating to the offering of the Notes (collectively with the Base Prospectus, the “Prospectus Supplement”); the Indenture and the Notes. In addition, we have examined such other instruments, documents, certificates and records which we have deemed relevant and necessary for the basis of our opinion hereinafter expressed. In such examination, we have assumed: (i) the authenticity of original documents and